Trend of Sex Differences and Predictors of Complications of Cardiac Electronic Device Implantations in the Southeast Anatolian Region of Turkey: An Observational Study
Journal Title: European Journal of Therapeutics - Year 2022, Vol 28, Issue 2
Abstract
Objective: The comparison of complications after cardiac implantable electronic device procedures has not been studied adequately between both genders. Here, we examined the effect of gender on complications in the Southeast Anatolian Region of Turkey. Methods: A total of 1640 patients from 3 centers in the Southeast Anatolian Region of Turkey were randomly selected. We compared major adverse cardiac events (clinically significant hematoma, pericardial effusion or tamponade, pneumothorax, and device infection) between genders. Univariate and multivariate analyses were plotted to identify predictors of outcomes between both genders. Results: The overall rate of major adverse cardiac events was 3.8% (63 of 1640). Major adverse cardiac events occurred in 4.1% (40 of 983) of the men and 3.5% (23 of 657) in the women groups (P=.557). The most complications were device-related infection (2.1%) and pneumothorax (1.3%) in both genders. Single- and dual-chamber pacemakers were more implanted in women than in men (11.7% vs. 6.2% and 32.6% vs. 20.1%, respectively, P < .001). On the contrary, single- and dual-chamber implantable cardioverter defibrillators were more implanted in men than in women (38.1% vs. 19.6% and 8.5% vs. 4.1%, respectively, P < .001). Additionally, warfarin treatment and history of heart failure were found predictors of major adverse cardiac events in multivariable analysis. Conclusions: This small-scale, real-life patient data revealed no remarkable distinction in terms of complications between both genders. Multinational randomized large-scale cohort trials are required to support our results
Authors and Affiliations
Muhammed Demir, Mehmet Özbek, Nihat Polat, Adem Aktan, Bünyamin Yıldırım, Lokman Argun, Kamran İldırımlı, Kenan Ateş, Cansu Öztürk, Tuncay Güzel, Raif Kılıç, Nizamettin Toprak
Keywords
Related Articles
- EP ID EP720503
- DOI -
- Views 35
- Downloads 0
Should Women Between the Ages of 25 and 30 Get Tested for HPV?
Objectives: The aim of this study is to discuss whether performing the human papillomavirus test on women aged 25-30 in Turkey has any effect on preventing cervical cancer. It is aimed to reevaluate the screening progra...
Serum Nuclear Factor Erythroid-2 Related Factor-2 (NRF2) as an Indicator of Oxidative Stress is Related to Coronary in-Stent Restenosis
Objective: In the treatment of coronary artery disease, stent implantation has become the standard treatment, but development of in-stent restenosis (ISR) limits the benefit of this treatment modality. Methods: Based...
New Age Borders Obtained from Spot Photoscreener by Using Multivariate Cluster Analysis
Objective: The aim of this study is to analyze all the variables obtained from photoscreener using hierarchical cluster analysis to create more homogeneous age groups for more reliable and consistent measurement by phot...
News from the European Journal of Therapeutics: A new issue and a new editorial board
Dear Colleagues, In the previous editorial paper published by Balat et al. [1] as an Early View Article a few months ago, it was reported that there were changes in the Editorial Team of the European Journal of Therap...
Attenuation of Senescence-Induced Oxidative Exacerbations in Aged Rat Testis by Ferula Elaeochytris Root Extract
Objective: Age brings about changes to the oxidant and antioxidant balance of male testis that give rise to loss of fertility. The Ferula elaeochytris root extract (FE), contents antioxidant and anti-inflammatory compon...